We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $46.3B Turnover 4.85%
1-Year Est. Return 43.9%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+43.9%
3 Year Est. Return
+135.96%
5 Year Est. Return
+174.68%
10 Year Est. Return
+647.83%
AUM
$43.9B
AUM Growth
+$2.15B
Cap. Flow
+$941M
Cap. Flow %
2.15%
Top 10 Hldgs %
38.78%
Holding
1,752
New
25
Increased
441
Reduced
297
Closed
24
Avg Time Held
5.6 years
Top 10 Avg Time Held
4.6 years
Top 20 Avg Time Held
3.4 years

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$166M
2
MU icon
Micron Technology
MU
+$148M
3
FERG icon
Ferguson
FERG
+$131M
4
AMD icon
Advanced Micro Devices
AMD
+$107M
5
GEV icon
GE Vernova
GEV
+$94.9M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$262M
2
TMUS icon
T-Mobile US
TMUS
+$167M
3
VZ icon
Verizon
VZ
+$114M
4
NFLX icon
Netflix
NFLX
+$84.4M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$74.2M

Sector Composition

Rank Sector Weight
1 Technology 34.5%
2 Healthcare 13.82%
3 Communication Services 13.35%
4 Financials 13.33%
5 Consumer Discretionary 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GNL icon
1426
Global Net Lease
GNL
$1.72B
$80K ﹤0.01%
9,311
– –
2022 Q2
14 quarters
IRON icon
1427
Disc Medicine
IRON
$2.18B
$80K ﹤0.01%
+1,011
New +$85.4K
2025 Q4
0 quarters
JOE icon
1428
St. Joe Company
JOE
$3.89B
$80K ﹤0.01%
1,346
– –
2018 Q2
30 quarters
SXI icon
1429
Standex International
SXI
$3.25B
$80K ﹤0.01%
369
– –
2022 Q2
14 quarters
APLE icon
1430
Apple Hospitality REIT
APLE
$4.03B
$79K ﹤0.01%
6,685
– –
2023 Q3
9 quarters
CPRX icon
1431
DELISTED
Catalyst Pharmaceutical
CPRX
$79K ﹤0.01%
3,387
– –
2022 Q3
13 quarters
CXT icon
1432
Crane NXT
CXT
$3.15B
$79K ﹤0.01%
1,673
– –
2023 Q2
10 quarters
IPGP icon
1433
IPG Photonics
IPGP
$3.02B
$79K ﹤0.01%
1,105
+391
+55% +$31.9K
2017 Q4
32 quarters
OI icon
1434
O-I Glass
OI
$896M
$79K ﹤0.01%
5,321
– –
2022 Q2
14 quarters
SMG icon
1435
ScottsMiracle-Gro
SMG
$3.18B
$79K ﹤0.01%
1,347
– –
2023 Q3
9 quarters
VCEL icon
1436
Vericel Corp
VCEL
$2.05B
$79K ﹤0.01%
2,191
– –
2022 Q2
14 quarters
VCTR icon
1437
Victory Capital Holdings
VCTR
$6.68B
$79K ﹤0.01%
1,252
– –
2025 Q1
3 quarters
VIRT icon
1438
Virtu Financial
VIRT
$5.02B
$79K ﹤0.01%
2,377
– –
2024 Q2
6 quarters
ARI icon
1439
Apollo Commercial Real Estate
ARI
$820M
$78K ﹤0.01%
8,092
+3,985
+97% +$39.9K
2022 Q2
14 quarters
CAR icon
1440
Avis
CAR
$3.63B
$78K ﹤0.01%
607
– –
2023 Q3
9 quarters
CLSK icon
1441
CleanSpark
CLSK
$2.16B
$78K ﹤0.01%
7,746
– –
2024 Q1
7 quarters
EYE icon
1442
National Vision
EYE
$1.38B
$78K ﹤0.01%
3,011
– –
2025 Q3
1 quarter
FLO icon
1443
Flowers Foods
FLO
$1.3B
$78K ﹤0.01%
7,134
– –
2023 Q3
9 quarters
GRBK icon
1444
Green Brick Partners
GRBK
$2.63B
$78K ﹤0.01%
1,239
– –
2022 Q3
13 quarters
GT icon
1445
Goodyear
GT
$1.24B
$78K ﹤0.01%
8,903
– –
2023 Q3
9 quarters
HUBG icon
1446
HUB Group
HUBG
$1.62B
$78K ﹤0.01%
1,830
– –
2018 Q3
29 quarters
KMPR icon
1447
Kemper
KMPR
$1.72B
$78K ﹤0.01%
1,926
– –
2023 Q3
9 quarters
OCUL icon
1448
Ocular Therapeutix
OCUL
$1.51B
$78K ﹤0.01%
+6,462
New +$78.5K
2025 Q4
0 quarters
PRDO icon
1449
Perdoceo Education
PRDO
$2.11B
$78K ﹤0.01%
2,654
+913
+52% +$28.8K
2022 Q2
14 quarters
SONO icon
1450
Sonos
SONO
$2.05B
$78K ﹤0.01%
4,465
– –
2022 Q2
14 quarters

Similar funds

KBC Group's Q4 2025 Portfolio in Review

As of Q4 2025, KBC Group held 1,752 positions worth $43.9B, up 5.2% from $41.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 2.8%. KBC Group opened 25 new positions and exited 24, leaving the 1,752-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Communication Services.

  • KBC Group's largest Q4 2025 buy was Qnity Electronics Inc: 149,289 shares worth $12.2M.
  • KBC Group added most to Abbott in Q4 2025, an estimated $166M increase.
  • KBC Group's biggest Q4 2025 reduction was T-Mobile US, cutting an estimated $167M.
  • KBC Group fully exited AbbVie in Q4 2025, selling an estimated $262M.
  • KBC Group's ten largest holdings make up 39% of its $43.9B portfolio in Q4 2025.
  • KBC Group opened 25 new positions and closed 24 in Q4 2025.
  • KBC Group's portfolio value rose 5.2% quarter-over-quarter to $43.9B.

Based on KBC Group's 13F filing for Q4 2025, filed 26 Jan 2026.